The REVOX sterilization process uses a room-temperature vaporized peracetic acid (VPA) method to achieve exceptionally low chemical residuals and unsurpassed materials compatibility. The REVOX technology eliminates inefficiencies associated with preconditioning and lengthy poststerilization wait times. In 2014, the FDA granted clearance to a Class II implantable device utilizing the REVOX sterilization process.
Ready to meet the companies at the forefront of design and manufacturing innovation in 2017? Search below to view hundreds of exhibitors in our online database.
To find specific exhibitors, simply filter by keyword.